Why is antimicrobial de-escalation under-prescribed for urinary tract infections?
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
To assess the frequency of de-escalation in inpatients treated for community-acquired urinary tract infection and the frequency of conditions legitimating not de-escalating therapy.
A retrospective study of inpatients (age >15 years) at a large academic hospital who were empirically treated for urinary tract infections due to Escherichia coli susceptible to at least one of the following antibacterial agents: amoxicillin, co-amoxiclav, and cotrimoxazole. De-escalation was defined as the replacement of the empirical broad-spectrum therapy by amoxicillin, co-amoxiclav, or cotrimoxazole.
Eighty patients were included. De-escalation was prescribed for 32 of 69 patients for whom it was possible from both a bacteriological and clinical point of view (46 %, 95 % CI, 34–59 %). Initial treatment was switched to amoxicillin (n = 21), co-amoxiclav (n = 2), or cotrimoxazole (n = 8). Thirteen conditions justifying not de-escalating antibacterial therapy were detected in 11 of 48 patients who were not de-escalated (23 %, 95 % CI, 12–37 %): shock, n = 5; renal abscess, n = 1; obstructive uropathy, n = 4; bacterial resistance or clinical contraindication to both cotrimoxazole and β-lactams, n = 3.
De-escalation is under-prescribed for urinary tract infections. Omission of de-escalation is seldom legitimate. Interventions aiming to de-escalate antibacterial therapy for UTIs should be actively implemented.
- Paterson, DL (2008) Impact of antibiotic resistance in gram-negative bacilli on empirical and definitive antibiotic therapy. Clin Infect Dis 47: pp. S14-S20 CrossRef
- Dellit, TH, Owens, RC, McGowan, JE, Gerding, DN, Weinstein, RA, Burke, JP (2007) Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 44: pp. 159-177 CrossRef
- Spellberg, B, Blaser, M, Guidos, RJ, Boucher, HW, Bradley, JS, Eisenstein, BI (2011) Combating antimicrobial resistance: policy recommendations to save lives. Clin Infect Dis 52: pp. S397-S428
- Carlet, J, Collignon, P, Goldmann, D, Goossens, H, Gyssens, IC, Harbarth, S (2011) Society’s failure to protect a precious resource: antibiotics. Lancet 378: pp. 369-371 CrossRef
- Kaki, R, Elligsen, M, Walker, S, Simor, A, Palmay, L, Daneman, N (2011) Impact of antimicrobial stewardship in critical care: a systematic review. J Antimicrob Chemother 66: pp. 1223-1230 CrossRef
- Niederman, MS, Soulountsi, V (2011) De-escalation therapy: is it valuable for the management of ventilator-associated pneumonia?. Clin Chest Med 32: pp. 517-534 CrossRef
- Donaldson, AD, Barkham, T (2010) De-escalation for amoxicillin-susceptible Escherichia coli: easier said than done. J Hosp Infect 74: pp. 304-305 CrossRef
- Gupta, K, Hooton, TM, Naber, KG, Wullt, B, Colgan, R, Miller, LG (2011) International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 52: pp. e103-e120 CrossRef
- Paterson, DL (2004) “Collateral damage” from cephalosporin or quinolone antibiotic therapy. Clin Infect Dis 38: pp. S341-S345 CrossRef
- Schito, GC, Naber, KG, Botto, H, Palou, J, Mazzei, T, Gualco, L (2009) The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int J Antimicrob Agents 34: pp. 407-413 CrossRef
- Kahlmeter, G, Poulsen, HO (2012) Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO.SENS study revisited. Int J Antimicrob Agents 39: pp. 45-51 CrossRef
- Lipsky, BA, Byren, I, Hoey, CT (2010) Treatment of bacterial prostatitis. Clin Infect Dis 50: pp. 1641-1652 CrossRef
- Why is antimicrobial de-escalation under-prescribed for urinary tract infections?
Volume 41, Issue 1 , pp 211-214
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Escherichia coli
- Urinary tract infection
- Industry Sectors
- Author Affiliations
- 1. Emergency Department, Nantes University Hospital, 1 Place Alexis-Ricordeau, 44000, Nantes, France
- 2. Faculté de Médecine, Université de Nantes, EA3826 Thérapeutiques Cliniques et Expérimentales des Infections, 1 Rue Gaston-Veil, 44000, Nantes, France
- 3. Infectious Diseases Department, Nantes University Hospital, 1 Place Alexis-Ricordeau, 44000, Nantes, France
- 4. Microbiology Department, Nantes University Hospital, 1 Place Alexis-Ricordeau, 44000, Nantes, France